Related Experiment Video

Updated: Jan 4, 2026

High-resolution Respirometry to Measure Mitochondrial Function of Intact Beta Cells in the Presence of Natural Compounds
12:32

High-resolution Respirometry to Measure Mitochondrial Function of Intact Beta Cells in the Presence of Natural Compounds

Published on: January 23, 2018

12.9K

GLP-1 Receptor Activation Abrogates β-Cell Dysfunction by PKA Cα-Mediated Degradation of Thioredoxin Interacting

Shijun He1, Wenyu Wu2, Yihong Wan1

  • 1State Key Laboratory of Organ Failure Research, Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, China.

Frontiers in Pharmacology
|November 12, 2019
PubMed

Insights

Exendin-4 protects pancreatic beta cells by degrading TXNIP via PKA Cα. This pathway is crucial for maintaining insulin secretion and reducing inflammation, highlighting a key molecular mechanism.

Area of Science:

  • Molecular Endocrinology
  • Cellular Biology
  • Diabetes Research

Background:

  • Glucagon-like peptide 1 receptor (GLP-1R) agonists, like Exendin-4, improve pancreatic beta-cell function via protein kinase A (PKA).
  • The precise downstream molecular mechanisms of GLP-1R agonists in beta-cells remain incompletely understood.
  • TXNIP (Thioredoxin-interacting protein) is implicated in beta-cell dysfunction and inflammation.

Purpose of the Study:

  • To elucidate the downstream molecular mechanisms by which Exendin-4 exerts its protective effects on pancreatic beta-cells.
  • To investigate the role of PKA Cα and TXNIP in mediating the functions of Exendin-4 in beta-cells.
  • To determine the impact of PKA Cα-mediated TXNIP phosphorylation and degradation on beta-cell function and inflammation.

Main Methods:

  • Utilized INS-1 cells, PKA activators (Exendin-4, FSK), and CRISPR-Cas9 gene editing for PKA Cα knockout (KO).
  • Employed bimolecular fluorescence complementation (BiFC) and co-immunoprecipitation (Co-IP) assays to assess protein interactions.
  • Analyzed TXNIP and PKA Cα levels, TXNIP phosphorylation (Ser307/308), protein degradation via the proteasome pathway, and inflammation gene expression.

Main Results:

  • PKA Cα directly interacts with and phosphorylates TXNIP at Ser307 and Ser308, leading to proteasomal degradation.
  • PKA Cα overexpression decreased TXNIP levels, while PKA Cα-KO increased TXNIP levels, impairing beta-cell function and increasing inflammation.
  • Exendin-4's protective effects on TXNIP levels and inflammation were dependent on functional PKA Cα and TXNIP phosphorylation sites.

Conclusions:

  • PKA Cα-mediated TXNIP phosphorylation and subsequent degradation are critical downstream events in the beta-cell protective actions of Exendin-4.
  • The PKA Cα/TXNIP signaling axis plays a vital role in maintaining pancreatic beta-cell function, insulin secretion, and suppressing inflammation.
  • This study reveals a novel molecular pathway contributing to the therapeutic potential of GLP-1R agonists in diabetes.
Keywords:
PKAPancreatic beta cellsbeta cell dysfunctioner stressexendin 4

More Related Videos

Mixed Primary Cultures of Murine Small Intestine Intended for the Study of Gut Hormone Secretion and Live Cell Imaging of Enteroendocrine Cells09:16

Mixed Primary Cultures of Murine Small Intestine Intended for the Study of Gut Hormone Secretion and Live Cell Imaging of Enteroendocrine Cells

Published on: April 20, 2017

16.0K
Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy08:47

Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy

Published on: December 7, 2017

10.2K

Related Concept Videos

Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
790
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
7.1K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
8.1K
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
7.8K
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
2.5K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
16.8K